RT Journal Article
SR Electronic
T1 Insulin pricing and other major diabetes-related concerns in the USA: A study of 46,400 Tweets between 2017 and 2019
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.04.20016527
DO 10.1101/2020.01.04.20016527
A1 Adrian Ahne
A1 Francisco Orchard
A1 Xavier Tannier
A1 Camille Perchoux
A1 Beverley Balkau
A1 Sherry Pagoto
A1 Jessica L Harding
A1 Thomas Czernichow
A1 Guy Fagherazzi
YR 2020
UL http://medrxiv.org/content/early/2020/01/10/2020.01.04.20016527.abstract
AB Objective Little is known about the concerns of people living with diabetes. This study aims to identify key diabetes-related concerns in the USA and primary emotions associated with those concerns using information shared on Twitter.Research Design and Methods A total of 11.7 million diabetes-related tweets in English were collected between April 2017 and July 2019. Machine learning methods were used to filter tweets with personal content, to geolocate (to the US) and to identify clusters of tweets with emotional elements. A sentiment analysis was then applied to each cluster.Results We identified 46,400 tweets with emotional elements in the USA from which 30 clusters were identified; five clusters (18% of tweets) were related to insulin pricing with both positive emotions (joy, love) referring to advocacy for affordable insulin and sadness emotions related to the frustration of insulin prices, five clusters (12% of tweets) to solidarity and support with a majority of joy and love emotions expressed. The most negative topics (10% of tweets) were related to diabetes distress (24% sadness, 27% anger, 21% fear elements), to diabetic and insulin shocks (45% anger, 46% fear) and comorbidities (40% sadness).Conclusions Our work has enabled us to describe the main topics of interest about diabetes and their associated emotions. Insulin pricing is a central diabetes-related concern and is associated with feelings of sadness. Social media data are complementary to traditional diabetes epidemiology and can contribute to public decision making around key topics of interest around diabetes.What is already known about this subject?It is very challenging to collect data a population level to truly understand what are the key concerns of people with diabetes in the real lifeSocial media such as Twitter can serve as a relevant source of informationThere are key challenges for a global and fair access to insulinWhat are the new findings?This work represents an unprecedented overview of the large diabetes online community in the USAWith 18% of the tweets related to insulin pricing, we have observed that it is a major concern in the diabetes community in the USA. People regularly express fear, anger and sadness about potential diabetes-related complications and comorbidities. However, there is a great amount of support and solidarity among the diabetes online community with numerous posts related to positive emotionsHow might these results change the focus of research or clinical practice?Our work presents a reproducible approach to easily capture relevant information about the main concerns of people with diabetes that is usually not available in typical clinical or epidemiological settings. This could help to shape more relevant public health actions by targeting what really matters to people with diabetes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been supported by the MSDAvenir Foundation, the French Speaking Diabetes Society and the Luxembourg Institute of Health. These study sponsors had no role in the design nor the interpretation of the results of the present study. Adrian Ahne, Francisco Orchard and Thomas Czernichow are supported by Epiconcept Company. Epiconcept was involved in the data collection and writing of the report. No study sponsor influenced the decision to submit the paper for publication. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code is publicly available in this github repository: https://github.com/WDDS/Tweet-Diabetes-Classification Data is available upon reasonable request https://github.com/WDDS/Tweet-Diabetes-Classification